DOTmed June 10, 2024
French-American medical technology company Moon Surgical has received FDA clearance for the commercial version of its Maestro robotic surgery system, paving the way for the system’s deployment in the U.S. and Europe through a Limited Market Release ahead of a broader launch in 2025.
The Paris- and San Francisco-based company aims to revolutionize laparoscopic surgery with its Maestro system, designed to enhance efficiency and support operating room teams in performing the 18.8 million annual soft tissue surgical procedures not currently addressed by existing telerobotic systems. Anne Osdoit, CEO of Moon Surgical and partner at Sofinnova Partners’ medtech accelerator, MD Start, emphasized the system’s potential to optimize surgical services through data-driven insights and integration into existing clinical workflows.
“At Moon Surgical,...
Today's Sponsors
Today's Sponsor